Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome

Brain

Volumn 136, Issue 11, 2013, Pages 3441-3450

  Khoury, Michael N ^a   Gheuens, Sarah ^a,c   Ngo, Long ^b   Wang, Xiaoen ^b   Alsop, David C ^b   Koralnik, Igor J ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BIOGEN   (United States)

Author keywords

Magnetic resonance imaging; Neuroimmunology; Neuroinflammation; Perfusion imaging; Progressive multifocal leukoencephalopathy

Indexed keywords

ADAPTIVE IMMUNITY; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BRAIN PERFUSION; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; DISEASE ASSOCIATION; DISEASE COURSE; ETHNICITY; FEMALE; GRAY MATTER; HUMAN; HYPERTENSION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KARNOFSKY PERFORMANCE STATUS; MALE; PERFUSION WEIGHTED IMAGING; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RANKIN SCALE; RISK FACTOR; SPIN LABELING; SYMPTOM;

EID: 84890509187     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt268     Document Type: Article

References (58)

1. Abrams J. Nitrate delivery systems in perspective. A decade of progress. Am J Med 1984; 76: 38-46.
2. Aiello S, Noris M, Piccinini G, Tomasoni S, Casiraghi F, Bonazzola S, et al. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self-And alloantigens. J Immunol 2000; 164: 4649-58.
3. Akaike T, Maeda H. Nitric oxide and virus infection. Immunology 2000; 101: 300-8.
4. Alsop DC, Detre JA. Reduced transit-Time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996; 16: 1236-49.
5. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000; 47: 93-100.
6. Ances BM, Roc AC, Wang J, Korczykowski M, Okawa J, Stern J, et al. Caudate blood flow and volume are reduced in HIV + neurocognitively impaired patients. Neurology 2006; 66: 862-6.
7. Ances BM, Sisti D, Vaida F, Liang CL, Leontiev O, Perthen JE, et al. Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology 2009; 73: 702-8.
8. Astrom KE, Mancall EL, Richardson EP Jr. Progressive multifocal leukoencephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958; 81: 93-111.
9. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998; 4: 59-68.
10. Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 2013; 80: 1430-8.
11. Bergui M, Bradac GB, Oguz KK, Boghi A, Geda C, Gatti G, et al. Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology 2004; 46: 22-5.
12. Chalela JA, Alsop DC, Gonzalez-Atavales JB, Maldjian JA, Kasner SE, Detre JA. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 2000; 31: 680-7.
13. Charriaut-Marlangue C, Bonnin P, Pham H, Loron G, Leger PL, Gressens P, et al. Nitric oxide signaling in the brain: a new target for inhaled nitric oxide? Ann Neurol 2013. [Epub ahead of print]
14. Cosottini M, Tavarelli C, Del Bono L, Doria G, Giannelli M, De Cori S, et al. Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy. Eur Radiol 2008; 18: 1024-30.
15. Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008; 60: 1488-97.
16. Dai W, Robson PM, Shankaranarayanan A, Alsop DC. Reduced resolution transit delay prescan for quantitative continuous arterial spin labeling perfusion imaging. Magn Reson Med 2012; 67 (5): 1252-65.
17. Deichmann R, Schwarzbauer C, Turner R. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T. Neuroimage 2004; 21: 757-67.
18. Detre JA, Rao H, Wang DJ, Chen YF, Wang Z. Applications of arterial spin labeled MRI in the brain. J Magn Reson Imaging 2012; 35: 1026-37.
19. Du AT, Jahng GH, Hayasaka S, Kramer JH, Rosen HJ, Gorno-Tempini ML, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 2006; 67: 1215-20.
20. Duhameau B, Ferre JC, Jannin P, Gauvrit JY, Verin M, Millet B, et al. Chronic and treatment-resistant depression: a study using arterial spin labeling perfusion MRI at 3Tesla. Psychiatry Res 2010; 182: 111-6.
21. Falco V, Olmo M, del Saz SV, Guelar A, Santos JR, Gutierrez M, et al. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study. J Acquir Immune Defic Syndr 2008; 49: 26-31.
22. Faraci FM, Breese KR. Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-Aspartate receptors in brain. Circ Res 1993; 72: 476-80.
23. Gasnault J, Costagliola D, Hendel-Chavez H, Dulioust A, Pakianather S, Mazet AA, et al. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. PLoS One 2011; 6: e20967.
24. Gheuens S, Wuthrich C, Koralnik IJ. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol 2013; 8: 189-215.
25. Gheuens S, Ngo L, Wang X, Alsop DC, Lenkinski RE, Koralnik IJ. Metabolic profile of PML lesions in patients with and without IRIS: an observational study. Neurology 2012; 79: 1041-8.
26. Gheuens S, Bord E, Kesari S, Simpson DM, Gandhi RT, Clifford DB, et al. Role of CD4 + and CD8 + T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 2011; 85: 7256-63.
27. Harrison DM, Newsome SD, Skolasky RL, McArthur JC, Nath A. Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy. J Neuroimmunol 2011; 238: 81-6.
28. Hooper DC, Ohnishi ST, Kean R, Numagami Y, Dietzschold B, Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc Natl Acad Sci USA 1995; 92: 5312-6.
29. Horger M, Beschorner R, Beck R, Nagele T, Schulze M, Ernemann U, et al. Common and uncommon imaging findings in progressive multifocal leukoencephalopathy (PML) with differential diagnostic considerations. Clin Neurol Neurosurg 2012; 114: 1123-30.
30. Johnson T, Nath A. Immune reconstitution inflammatory syndrome and the central nervous system. Curr Opin Neurol 2011; 24: 284-90.
31. Katz-Brull R, Lenkinski RE, Du Pasquier RA, Koralnik IJ. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology 2004; 63: 897-900.
32. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005; 353: 369-74.
33. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005; 353: 375-81.
34. Leenders KL, Beaney RP, Brooks DJ, Lammertsma AA, Heather JD, McKenzie CG. Dexamethasone treatment of brain tumor patients: effects on regional cerebral blood flow, blood volume, and oxygen utilization. Neurology 1985; 35: 1610-6.
35. Mader I, Herrlinger U, Klose U, Schmidt F, Kuker W. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology 2003; 45: 717-21.
36. Maleki N, Dai W, Alsop DC. Optimization of background suppression for arterial spin labeling perfusion imaging. Magma 2012; 25: 127-33.
37. Martin-Blondel G, Delobel P, Blancher A, Massip P, Marchou B, Liblau RS, et al. Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain 2011; 134 (Pt 4): 928-46.
38. Marzocchetti A, Tompkins T, Clifford DB, Gandhi RT, Kesari S, Berger JR, et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 2009; 73: 1551-8.
39. Niedbala W, Cai B, Liew FY. Role of nitric oxide in the regulation of T cell functions. Ann Rheum Dis 2006; 65 (Suppl 3): iii37-40.
40. Ozsunar Y, Mullins ME, Kwong K, Hochberg FH, Ament C, Schaefer PW, et al. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Acad Radiol 2010; 17: 282-90.
41. Pfefferbaum A, Chanraud S, Pitel AL, Shankaranarayanan A, Alsop DC, Rohlfing T, et al. Volumetric cerebral perfusion imaging in healthy adults: regional distribution, laterality, and repeatability of pulsed continuous arterial spin labeling (PCASL). Psychiatry Res 2010; 182: 266-73.
42. Rashid W, Parkes LM, Ingle GT, Chard DT, Toosy AT, Altmann DR, et al. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry 2004; 75: 1288-93.
43. Salerno L, Sorrenti V, Di Giacomo C, Romeo G, Siracusa MA. Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr Pharm Des 2002; 8: 177-200.
44. Scheef L, Manka C, Daamen M, Kuhn KU, Maier W, Schild HH, et al. Resting-state perfusion in nonmedicated schizophrenic patients: a continuous arterial spin-labeling 3.0-T MR study. Radiology 2010; 256: 253-60.
45. Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist 2005; 11: 400-7.
46. Sun HY, Singh N. Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients. Curr Opin Infect Dis 2009; 22: 394-402.
47. Tanaka Y, Nagaoka T, Nair G, Ohno K, Duong TQ. Arterial spin labeling and dynamic susceptibility contrast CBF MRI in postischemic hyperperfusion, hypercapnia, and after mannitol injection. J Cereb Blood Flow Metab 2011; 31: 1403-11.
48. Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, Wiggert B, et al. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med 1999; 189: 219-30.
49. Tsutsumi H, Takeuchi R, Ohsaki M, Seki K, Chiba S. Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression. J Leukoc Biol 1999; 66: 99-104.
50. van der Veen RC. Nitric oxide and T helper cell immunity. Int Immunopharmacol 2001; 1: 1491-500.
51. van Gelderen P, de Zwart JA, Duyn JH. Pittfalls of MRI measurement of white matter perfusion based on arterial spin labeling. Magn Reson Med 2008; 59: 788-95.
52. van Laar PJ, van der Graaf Y, Mali WP, van der Grond J, Hendrikse J. Effect of cerebrovascular risk factors on regional cerebral blood flow. Radiology 2008; 246: 198-204.
53. van Osch MJ, Teeuwisse WM, van Walderveen MA, Hendrikse J, Kies DA, van Buchem MA. Can arterial spin labeling detect white matter perfusion signal? Magn Reson Med 2009; 62: 165-73.
54. Vendrely A, Bienvenu B, Gasnault J, Thiebault JB, Salmon D, Gray F. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 2005; 109: 449-55.
55. Wang DJ, Alger JR, Qiao JX, Hao Q, Hou S, Fiaz R, et al. The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke 2012; 43: 1018-24.
56. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 1992; 89: 212-6.
57. Ye FQ, Frank JA, Weinberger DR, McLaughlin AC. Noise reduction in 3D perfusion imaging by attenuating the static signal in arterial spin tagging (ASSIST). Magn Reson Med 2000; 44: 92-100.
58. Yousry TA, Pelletier D, Cadavid D, Gass A, Richert ND, Radue EW, et al. Magnetic resonance imaging pattern in natalizumab-Associated progressive multifocal leukoencephalopathy. Ann Neurol 2012; 72: 779-87.